Cognitive Longevity For Neurodegenerative Diseases
Our mission is to monitor brain health and personalise therapeutic interventions. We combine patented intracellular multi-omics analytics using DNA nanoprobes and AI to diagnose neurodegenerative diseases before symptoms manifest.
We Use Patented DNA Nanotechnology
A paradigm shift in understanding how Alzheimer's and Parkinson's diseases manifest opens up a whole new way of diagnosing, treating and managing the disease.
Quantitative Reporters For The Inside Of The Cell
Seven DNA-based probes, each reporting one chemistry from inside the organelle where it matters.
Accelerate Drug Development
Our ratio-metric assays are exceptional in their ability to quantify the key chemicals within endosomes (early, recycling, and late), lysosomes, and the golgi. They can be used to complement drug discovery and patient stratification, as well as assess drug efficacy as an end point in clinical trials for lysosomal storage disorders and numerous neurocognitive impairments.